Pierre Baillargeon
Papers
1
Total Citations
51
H-Index
1
About
Pierre Baillargeon is a leading figure in the development of advanced three-dimensional (3D) cell-based assay technologies for high-throughput screening (HTS) in early drug discovery. His primary research focuses on creating affordable, physiologically relevant 3D spheroid models that bridge the gap between traditional 2D cultures and in vivo systems. Among his most notable contributions is the automation of a magnetic 3D spheroid model technology, detailed in his highly cited 2019 paper (51 citations), which enables scalable, reproducible HTS applications. This work has significantly accelerated the adoption of 3D assays in pharmaceutical research, reducing costs and improving predictive accuracy for drug efficacy and toxicity. Baillargeon’s innovations have been instrumental in adapting novel microplate treatments and culturing techniques, making complex biological models accessible for routine screening. His impact is evident in the growing reliance on his methodologies across academic and industrial labs, with his research cited extensively as a cornerstone for next-generation drug discovery platforms. Through his dedication to automation and reproducibility, Baillargeon continues to empower researchers to explore disease mechanisms and therapeutic targets with unprecedented efficiency.
Research Focus
Key Achievements
Top Papers
- 1